Premium
Severe thrombocytopenia possibly related to readministration of eptifibatide
Author(s) -
ParadisoHardy Fran L.,
Madan Mina,
Radhakrishnan Sam,
Hurden Susan,
Cohen Eric A.
Publication year - 2001
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.1239
Subject(s) - eptifibatide , medicine , percutaneous coronary intervention , platelet , cardiology , anesthesia , myocardial infarction
Thrombocytopenia following eptifibatide therapy is a rare event, and acute severe thrombocytopenia following readministration has not been reported. We describe a case of acute severe thrombocytopenia following reexposure to eptifibatide during percutaneous coronary intervention. We continue to monitor platelet counts at 2–4 hr and 16–24 hr following administration of any glycoprotein IIb/IIIa inhibitor. Cathet Cardiovasc Intervent 2001;54:63–67. © 2001 Wiley‐Liss, Inc.